News Summary
NegativeMicrochip delivered a strong Q1 FY2027 earnings beat ($0.76 EPS vs. $0.70 consensus) with 38% YoY revenue growth and completed the strategic Hailo acquisition for edge AI processors, but faces material headwinds including COO resignation, analyst price target cuts citing inventory concerns, and a 21% three-month stock decline that has erased 2026 gains.
Red flags
- •COO Richard Simoncic resignation effective August 17, 2026, with no successor identified or transition plan disclosed
- •Wells Fargo and TD Cowen reduced price targets (to $88 and $90 respectively) citing elevated channel inventory and margin compression concerns
- •Stock declined ~21% over three months despite earnings beat, signaling investor concerns about forward guidance or competitive positioning
- •Non-GAAP gross margin included $38.5 million in capacity underutilization charges, indicating factory ramp challenges
Funds Buying (4)
| Fund | Manager | Shares Held | ∆ Shares | Position Value | % of Fund | QoQ | Status |
|---|---|---|---|---|---|---|---|
| Glenview Capital | Larry Robbins | 266K | +266K | $24M | 0.5% | — | NEW |
| Soros Fund Management | Soros Family Office | 228K | +228K | $21M | 0.3% | — | NEW |
| Point72 | Steve Cohen | 10.5M | +10.5M | $12M | <0.1% | — | NEW |
| Maverick Capital | Lee Ainslie | 7K | +7K | $1M | <0.1% | — | NEW |
Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.
Portfolio Context
Where MCHP ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.
position #35 of this fund's book
- 32BAUSCH PLUS LOMB CORP$32M
- 33BAKER HUGHES COMPANY$27M
- 34ELEVANCE HEALTH INC FORMERLY$26M
- 35MICROCHIP TECHNOLOGY INC.$24M
- 36BRUKER CORP$15M
- 37NOVARTIS AG$14M
- 38DIGITALOCEAN HLDGS INC$13M
Values are quarter-end position sizes. Shown only for funds where MCHP ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.
Insider Activity
Beneficial Ownership (13D/13G)
| Filer | Form | Shares | % of Class | Filed | Src |
|---|---|---|---|---|---|
| Vanguard Capital Management | SC 13G | 40.6M | 7.5% | 2026-04-30 | ↗ |
| Vanguard Portfolio Management | SC 13G | 32.5M | 6.0% | 2026-04-29 | ↗ |
SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.
Congressional Trading
| Member | Chamber | State | Type | Amount Range | Transaction Date | Filed | Src |
|---|---|---|---|---|---|---|---|
| Gilbert Cisneros | house | CA31 | BUY | $1,001 - $15,000 | 2026-06-30 | 2026-07-02 | ↗ |
| Alan Armstrong | senate | — | BUY | $1,001 - $15,000 | 2026-03-27 | 2026-07-21 | ↗ |
Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures.